Unnati Pharmax

Tazarotene – Tazret Gel
Composition: Tazarotene Topical Gel
International Trade Name: Tazorac®

Tazret Gel is a high-quality Tazarotene topical gel, a pharmaceutical equivalent of the internationally recognized retinoid marketed under the brand name Tazorac®. Manufactured in WHO-GMP certified facilities, Tazret Gel is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs, particularly in acne vulgaris, plaque psoriasis, and photoaged skin management.

Tazarotene is a third-generation topical retinoid that modulates keratinocyte differentiation, normalizes epidermal cell turnover, and reduces inflammation, enabling targeted therapy to improve skin texture, reduce lesions, and manage chronic dermatological conditions. Tazret Gel is primarily indicated for the treatment of mild to moderate acne vulgaris, plaque psoriasis, and signs of photoaging.

Tazret Gel is manufactured under stringent GMP and dermatology quality standards, ensuring consistent efficacy, safety, and long-term stability. The gel is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, tertiary care hospitals, government skin care programs, and international pharmaceutical distributors.

Soolantra Cream
Composition: Ivermectin 1% w/w Topical Cream
International Trade Name: Soolantra®

Soolantra Cream is a high-quality topical anti-parasitic and anti-inflammatory formulation containing ivermectin, designed for the effective treatment of rosacea and inflammatory skin conditions. Manufactured in WHO-GMP certified facilities, Soolantra Cream is supplied by trusted pharmaceutical exporters from India to support dermatology treatment programs worldwide.

Ivermectin works by targeting skin mites (Demodex species) and exerting anti-inflammatory effects, helping reduce papules, pustules, redness, and skin irritation associated with rosacea. Soolantra Cream is primarily indicated for the treatment of inflammatory lesions of rosacea in adult patients, providing both antimicrobial and soothing action for sensitive skin.

Soolantra Ivermectin Cream, anti-rosacea topical therapy, ivermectin cream for dermatology, inflammatory skin treatment, dermatology medicines exporter India, and topical dermatology product manufacturer India.

Soolantra Cream is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and skin tolerability. The cream is supplied in secure, patient-friendly, export-grade tubes with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Adaferin Gel
Composition: Adapalene Topical Gel
International Trade Name: Differin®

Adaferin Gel is a high-quality topical retinoid formulation containing adapalene, a third-generation retinoid widely recognized for its effectiveness in acne management. Manufactured in WHO-GMP certified facilities, Adaferin Gel is supplied by trusted pharmaceutical exporters from India to support dermatology treatment programs worldwide, particularly in the management of acne vulgaris.

Adapalene works by normalizing follicular epithelial differentiation, preventing comedone formation, and promoting skin cell turnover. It also exhibits anti-inflammatory properties, reducing redness and swelling associated with acne lesions. Adaferin Gel is primarily indicated for the treatment of mild to moderate acne vulgaris, including comedones (blackheads and whiteheads) and inflammatory lesions (papules and pustules), suitable for both adolescent and adult patients.

Adaferin Gel (Adapalene, Differin), topical retinoid acne gel, anti-acne therapy, comedolytic acne treatment, dermatology medicines exporter India, and topical dermatology product manufacturer India.

Adaferin Gel is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and skin tolerability. The gel is supplied in secure, patient-friendly, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, skin-care centers, and international pharmaceutical distributors.

Azelaic Acid 20% – Aziderm Cream (Finacea® Equivalent)

Composition:
Azelaic Acid 20% Cream

Aziderm 20 Cream is a high-strength topical dermatological formulation containing 20% Azelaic Acid, developed for the effective management of acne vulgaris, rosacea, melasma, post-inflammatory hyperpigmentation, and uneven skin tone. It is widely regarded as a therapeutic equivalent to the internationally recognized brand Finacea®, offering dependable clinical performance with good skin tolerance.

Azelaic Acid provides antibacterial, anti-inflammatory, comedolytic, and depigmenting effects. It inhibits the growth of Cutibacterium acnes, normalizes follicular keratinization to prevent clogged pores, reduces inflammation, and suppresses tyrosinase activity to limit melanin production. These combined actions help reduce active acne lesions, calm redness associated with rosacea, and visibly lighten dark spots and melasma.

Aziderm 20 Cream is primarily indicated for the topical treatment of moderate acne vulgaris, rosacea, melasma, post-acne pigmentation, and uneven skin tone, under dermatological supervision. Its smooth, non-greasy cream base ensures easy application, rapid absorption, and excellent patient compliance for daily dermatological use.

Azelaic Acid 20% cream, Aziderm 20, Finacea equivalent, anti-acne and rosacea treatment, skin brightening and depigmenting cream, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Aziderm 20 Cream is produced under stringent quality control standards, ensuring consistent potency, stability, and therapeutic efficacy. The cream is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Taxomus Forte Ointment – Tacrolimus

Composition:
Tacrolimus Ointment

Taxomus Forte Ointment is a high-quality topical immunomodulatory formulation containing Tacrolimus, specifically developed for the management of inflammatory skin disorders such as atopic dermatitis, eczema, and other chronic inflammatory dermatoses. This ointment provides targeted immunosuppressive action without the adverse effects associated with long-term topical corticosteroid use.

Tacrolimus works by inhibiting calcineurin, which reduces T-cell activation and the release of inflammatory cytokines in affected skin. This mechanism helps control itching, redness, and inflammation, allowing the skin to repair and restore its natural barrier function. Taxomus Forte Ointment is particularly useful in sensitive areas, such as the face and intertriginous regions, where corticosteroids may pose higher risks.

Taxomus Forte Ointment is primarily indicated for the topical treatment of moderate to severe atopic dermatitis and chronic inflammatory skin conditions under dermatological supervision. Its smooth, non-greasy ointment base ensures easy application, optimal absorption, and high patient compliance.

Taxomus Forte Ointment, Tacrolimus topical ointment, immunomodulatory dermatology ointment, atopic dermatitis therapy, eczema treatment, steroid-sparing ointment, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Taxomus Forte Ointment complies with stringent quality and safety standards, ensuring consistent efficacy, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, specialty skin centers, retail pharmacies, and international pharmaceutical distributors.

Azelex – Azelaic Acid Gel (Aziderm Gel)

Composition:
Azelaic Acid 10% w/w Gel

Azelex Gel is a high-quality topical dermatological formulation containing Azelaic Acid 10%, marketed as Aziderm Gel. Azelaic Acid is a naturally occurring dicarboxylic acid with antibacterial, anti-inflammatory, and keratolytic properties, making it a versatile and effective treatment for acne and pigmentation disorders.

Azelaic Acid works by inhibiting the growth of Propionibacterium acnes (Cutibacterium acnes), reducing inflammation, normalizing keratinization, and decreasing melanin production in hyperpigmented areas. This combination of actions helps treat mild to moderate acne, post-inflammatory hyperpigmentation (PIH), melasma, and uneven skin tone while promoting smoother, clearer skin.

Azelex Gel is primarily indicated for topical treatment of acne vulgaris, rosacea, hyperpigmentation, melasma, and other inflammatory or pigmentary skin disorders, as advised by dermatologists. Its lightweight, non-greasy gel base ensures quick absorption, good patient compliance, and suitability for daily use.

Keywords: Azelex Gel, Azelaic Acid 20% Gel, Aziderm Gel, acne treatment gel, anti-pigmentation gel, dermatology formulation, pharmaceutical exporter India, dermatology medicine manufacturer India.

Manufactured in WHO-GMP certified facilities, Azelex Gel meets strict pharmaceutical quality and safety standards, ensuring consistent efficacy, stability, and skin tolerability. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors seeking reliable acne and pigmentation treatment solutions.

Ezanic Azelaic Acid Cream
Composition: Azelaic Acid Cream
International Trade Name: Azelaic Acid Topical Cream

Ezanic is a high-quality Azelaic Acid Cream, formulated for the effective management of acne vulgaris, rosacea, and hyperpigmentation disorders. Manufactured in WHO-GMP certified facilities, Ezanic Cream is supplied by trusted pharmaceutical exporters from India to support global dermatology and aesthetic treatment programs.

Azelaic acid is a naturally occurring dicarboxylic acid with antibacterial, anti-inflammatory, keratolytic, and anti-tyrosinase properties. It works by reducing the growth of acne-causing bacteria (Cutibacterium acnes), normalizing follicular keratinization, decreasing inflammation, and inhibiting melanin synthesis. Ezanic Azelaic Acid Cream is primarily indicated for the treatment of mild to moderate acne vulgaris, papulopustular rosacea, and melasma or post-inflammatory hyperpigmentation (PIH), making it suitable for long-term dermatological use.

Ezanic Azelaic Acid Cream, azelaic acid topical cream, anti-acne and rosacea treatment, melasma and hyperpigmentation therapy, dermatology skin-care medicine, pharmaceutical exporter India, and topical dermatology product manufacturer India.

Ezanic Azelaic Acid Cream is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and excellent skin tolerability. The cream is supplied in secure, patient-friendly, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Aziderm 20% – Azelaic Acid Gel

Composition:
Azelaic Acid 20% Gel

Aziderm 20 Gel is a high-strength topical dermatological formulation containing 20% Azelaic Acid, designed to provide effective treatment for moderate to severe acne, hyperpigmentation, and melasma. Its multifunctional action combines antibacterial, anti-inflammatory, and depigmenting properties, making it suitable for both therapeutic and cosmetic dermatology applications.

Azelaic Acid works by inhibiting the growth of Cutibacterium acnes (formerly Propionibacterium acnes), reducing inflammation, normalizing keratinization, and preventing clogged pores. Additionally, it inhibits tyrosinase, helping to lighten hyperpigmented areas, post-acne marks, and melasma, promoting a more even and radiant skin tone. Its gel formulation ensures excellent penetration and rapid action, even in oily or acne-prone skin.

Aziderm 20 Gel is primarily indicated for the topical treatment of moderate to severe acne vulgaris, post-inflammatory hyperpigmentation, melasma, and uneven skin tone, under dermatological supervision. The lightweight, non-greasy gel base ensures easy application, high patient compliance, and suitability for daily use.

Aziderm 20% Gel, Azelaic Acid 20% topical gel, anti-acne gel, skin-brightening gel, hyperpigmentation treatment, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Aziderm 20 Gel meets stringent quality and safety standards, ensuring consistent efficacy, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Mytret 0.025% Gel
Composition: Tretinoin Gel 0.025% w/w
International Reference Brand: Retin-A®

Mytret 0.025% Gel is a high-quality topical retinoid formulation containing Tretinoin 0.025%, a bioequivalent alternative to globally recognized tretinoin brands such as Retin-A®. Tretinoin, a vitamin A derivative, is widely regarded as the gold-standard therapy in dermatology for the treatment of acne and photoaged skin.

Tretinoin works by normalizing follicular epithelial cell turnover, preventing comedone formation, reducing inflammatory acne lesions, and promoting collagen synthesis. At a lower strength of 0.025%, Mytret Gel offers effective clinical results with improved tolerability, making it suitable for patients new to retinoid therapy or those with sensitive skin.

Mytret 0.025% Gel is primarily indicated for the topical treatment of mild to moderate acne vulgaris, including blackheads and whiteheads, as well as for photoaging, fine lines, uneven skin texture, and hyperpigmentation under dermatological supervision. Its lightweight, non-greasy gel base allows rapid absorption, uniform distribution, and enhanced patient compliance.

Mytret 0.025% Gel, Tretinoin 0.025% gel, topical retinoid, acne treatment gel, anti-aging dermatology product, Retin-A alternative, pharmaceutical exporter India, and dermatology medicine manufacturer India.

Manufactured in WHO-GMP certified facilities, Mytret 0.025% Gel meets stringent pharmaceutical quality standards, ensuring consistent potency, safety, and product stability. The gel is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors seeking reliable tretinoin formulations.

Aczone – Dapsone Gel (Acnewar Gel)

Composition:
Dapsone 5% / 7.5% Topical Gel (depending on formulation)

Aczone (Acnewar Gel) is a high-quality topical anti-acne formulation containing Dapsone, an effective anti-inflammatory and antibacterial agent specifically designed for the management of acne vulgaris, including both inflammatory and non-inflammatory lesions. This gel provides dual benefits by reducing bacterial growth and controlling inflammation associated with acne.

Dapsone works by inhibiting neutrophil-mediated inflammatory processes and reducing the proliferation of Cutibacterium acnes (formerly Propionibacterium acnes), helping to clear papules, pustules, and comedones while preventing new acne formation. Its gentle yet effective action makes it suitable for sensitive and adult acne-prone skin.

Aczone (Acnewar Gel) is primarily indicated for the topical treatment of mild to moderate inflammatory acne vulgaris under dermatological supervision. The lightweight, non-greasy gel base ensures quick absorption, minimal irritation, and high patient compliance, making it ideal for daily use.

Aczone Gel, Dapsone topical gel, anti-acne therapy, inflammatory acne treatment, comedolytic and anti-inflammatory gel, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Aczone (Acnewar Gel) meets stringent quality and safety standards, ensuring consistent efficacy, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Tretinoin 0.1% – Mytret Gel

Composition:
Tretinoin Gel 0.1%

Mytret Gel 0.1% is a high-strength topical retinoid dermatological formulation containing Tretinoin 0.1%, widely regarded as a gold-standard therapy for the management of acne vulgaris and photo-damaged skin. This advanced gel formulation is designed to normalize follicular epithelial desquamation, prevent comedone formation, and promote rapid skin cell turnover.

Tretinoin works by stimulating epidermal renewal, unclogging pores, and reducing inflammation, thereby effectively treating comedonal and inflammatory acne. Additionally, its collagen-stimulating properties help improve fine lines, uneven skin texture, post-acne marks, and hyperpigmentation, making Mytret Gel 0.1% suitable for both therapeutic and corrective dermatological use.

Mytret Gel 0.1% is primarily indicated for the topical treatment of moderate to severe acne vulgaris, including blackheads, whiteheads, and inflammatory lesions, as well as for photoaging and skin rejuvenation under dermatological supervision. The lightweight, non-greasy gel base ensures fast absorption, enhanced penetration, and improved patient compliance.

Tretinoin 0.1% Gel, Mytret Gel, topical retinoid therapy, acne treatment gel, anti-aging retinoid, post-acne scar management, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Mytret Gel 0.1% complies with stringent pharmaceutical quality and safety standards, ensuring consistent potency, stability, and therapeutic efficacy. The product is supplied in secure, hygienic, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Melalite 15 Cream
Composition: Hydroquinone 4% + Octinoxate 7.5% + Benzophenone 3%
Packaging: 30 GM Tube
International Trade Name: Melalite® 15

Melalite 15 Cream is a high-quality dermatocosmetic depigmenting cream, formulated to provide effective treatment for hyperpigmentation, melasma, and sun-induced dark spots. Manufactured in WHO-GMP certified facilities, Melalite 15 Cream is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology and skin care programs.

Hydroquinone is a proven skin-lightening agent that inhibits melanin production, helping to reduce dark spots, uneven skin tone, and hyperpigmented patches. Octinoxate and Benzophenone act as broad-spectrum sunscreens, protecting the skin from harmful UVA and UVB radiation, thereby preventing further pigmentation. This combination ensures both therapeutic depigmentation and photoprotection in a single cream.

Melalite 15 Cream is primarily indicated for the topical treatment of melasma, chloasma, lentigines, post-inflammatory hyperpigmentation, and sun-induced dark spots, making it ideal for use in dermatology clinics and aesthetic skincare programs.

Melalite 15 Cream, hydroquinone depigmenting cream, melasma treatment cream, anti-dark spot skin cream, photoprotective skin lightening therapy, dermatology skin care medicine, and pharmaceutical exporter India.

Melalite 15 Cream is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, skin safety, and tolerability. The cream is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Faceclin Gel
Composition: Clindamycin 1% w/w + Adapalene 0.1% w/w
Dosage Form: Topical Gel

Faceclin Gel is a high-quality dermatological formulation combining Clindamycin, a topical antibiotic, with Adapalene, a synthetic retinoid. Manufactured in WHO-GMP certified facilities, Faceclin Gel ensures consistent quality, safety, and therapeutic effectiveness for acne management.

Clindamycin works by inhibiting bacterial protein synthesis, reducing Propionibacterium acnes proliferation, while Adapalene normalizes follicular epithelial cell turnover, prevents comedone formation, and reduces inflammation. Faceclin Gel is primarily indicated for the treatment of acne vulgaris, including inflammatory and non-inflammatory lesions, under dermatological supervision.

The gel is produced under stringent GMP and pharmaceutical quality standards, ensuring stability, safety, and efficacy. Supplied in secure, export-grade packaging with complete regulatory documentation, Faceclin Gel is suitable for dermatology clinics, hospitals, and pharmacies.

Derbeau Glycolic 12% Cream
Composition: Glycolic Acid 12% Cream
International Trade Name: Derbeau®

Derbeau Glycolic 12% Cream is a high-quality dermatological formulation containing Glycolic Acid, an alpha-hydroxy acid (AHA) known for its exfoliating and skin-renewing properties. Manufactured in WHO-GMP certified facilities, Derbeau Cream is supplied by trusted pharmaceutical exporters from India to support global dermatology and skincare treatment programs.

Glycolic Acid works by gently exfoliating the outer layer of dead skin cells, promoting cell turnover, improving skin texture, and enhancing overall skin radiance. Derbeau Glycolic 12% Cream helps reduce the appearance of fine lines, acne scars, hyperpigmentation, and uneven skin tone, while improving skin smoothness and clarity.

Derbeau Glycolic 12% Cream is primarily indicated for the management of acne-prone skin, melasma, photoaging, uneven skin tone, rough texture, and other conditions requiring controlled chemical exfoliation. It is suitable for adult patients under medical or dermatological supervision.

Derbeau Glycolic 12% Cream is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The cream is supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Skinlite Cream
Composition: Hydroquinone + Mometasone Furoate + Tretinoin Cream
International Trade Name: Skinlite®

Skinlite Cream is a high-quality triple-action dermatology formulation combining hydroquinone, mometasone furoate, and tretinoin, designed for the effective treatment of hyperpigmentation disorders and certain chronic inflammatory skin conditions. Manufactured in WHO-GMP certified facilities, Skinlite Cream is supplied by trusted pharmaceutical exporters from India to support global dermatology and aesthetic treatment programs.

Hydroquinone acts as a skin-lightening agent by inhibiting melanin production, helping reduce melasma, post-inflammatory hyperpigmentation, and other dark spots. Mometasone furoate is a potent corticosteroid that reduces inflammation, redness, and itching, while tretinoin (all-trans retinoic acid) accelerates skin cell turnover, enhancing the penetration of hydroquinone and improving the overall efficacy of the therapy. Skinlite Cream is primarily indicated for melasma, facial hyperpigmentation, and other localized pigmentary disorders, particularly in adult patients requiring combination therapy for optimal results.

Skinlite Cream (Hydroquinone + Mometasone + Tretinoin), triple-action depigmentation cream, melasma treatment cream, hydroquinone tretinoin combination, dermatology medicines exporter India, and topical dermatology product manufacturer India.

Skinlite Cream is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and skin tolerability. The cream is supplied in secure, patient-friendly, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Derbeau Glycolic 6% Cream

Composition:
Glycolic Acid Cream (6%)

Derbeau Glycolic 6% Cream is a high-quality alpha hydroxy acid (AHA)–based dermatological formulation designed to promote gentle exfoliation, skin renewal, and improved skin texture. With 6% Glycolic Acid, this cream effectively helps remove dead skin cells, unclog pores, and stimulate epidermal turnover, resulting in brighter, smoother, and more even-looking skin.

Glycolic Acid, a well-researched AHA, works by loosening the bonds between corneocytes, facilitating controlled exfoliation and enhancing skin regeneration. Derbeau Glycolic 6% Cream is commonly used to manage acne-prone skin, post-acne marks, uneven skin tone, hyperpigmentation, fine lines, and photo-damaged skin, while also improving the penetration and effectiveness of other topical dermatological treatments.

Derbeau Glycolic 6% Cream is primarily indicated for skin rejuvenation and correction of textural and pigmentary concerns, under dermatological guidance. Its smooth, non-greasy cream base ensures good tolerability, uniform application, and suitability for regular use in a wide range of skin types.

Derbeau Glycolic 6% Cream, glycolic acid 6% cream, AHA exfoliating cream, skin renewal therapy, hyperpigmentation treatment, acne scar management, dermatology cream, pharmaceutical exporter India, and cosmetic dermatology manufacturer India.

Manufactured in WHO-GMP certified facilities, Derbeau Glycolic 6% Cream adheres to stringent pharmaceutical quality and safety standards, ensuring consistent efficacy, stability, and patient satisfaction. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, aesthetic centers, hospitals, retail pharmacies, and international pharmaceutical distributors.

Deriva CMS Gel
Composition: Adapalene 0.1% w/w + Clindamycin 1% w/w
Dosage Form: Topical Gel

Deriva CMS Gel is a high-quality dermatological formulation combining Adapalene, a retinoid, with Clindamycin, a topical antibiotic, for the effective management of acne vulgaris. Manufactured in WHO-GMP certified facilities, Deriva CMS Gel ensures consistent quality and therapeutic performance.

Adapalene works by normalizing follicular epithelial desquamation, preventing microcomedone formation, and promoting skin cell turnover. Clindamycin inhibits the growth of acne-causing bacteria, reducing inflammation and preventing secondary infection. The synergistic effect of both ingredients helps reduce comedones, papules, and pustules while improving overall skin texture.

Deriva CMS Gel is primarily indicated for the treatment of mild to moderate inflammatory and non-inflammatory acne vulgaris under dermatological supervision.

The gel is produced under stringent GMP and pharmaceutical quality standards, ensuring safety, stability, and efficacy. Supplied in secure, export-grade packaging with complete regulatory documentation, Deriva CMS Gel is suitable for dermatology clinics, hospitals, and pharmacies.

Sefpil – Mandelic Acid Cream

Composition:
Mandelic Acid Cream

Sefpil Mandelic Acid Cream is a high-quality dermatological formulation containing Mandelic Acid, a gentle alpha hydroxy acid (AHA) known for its exfoliating, skin-brightening, and acne-controlling properties. This cream helps improve skin texture, reduce pigmentation, unclog pores, and promote a clearer, more radiant complexion.

Mandelic Acid works by loosening bonds between dead skin cells, facilitating controlled exfoliation, and stimulating skin renewal. Its larger molecular structure allows for gentle penetration, making it suitable for sensitive skin while effectively addressing acne, post-inflammatory hyperpigmentation, fine lines, and dull skin. The cream also aids in regulating sebum production, minimizing pore congestion, and enhancing overall skin health.

Sefpil Mandelic Acid Cream is primarily indicated for acne-prone and hyperpigmented skin, dull or uneven skin tone, and early signs of photoaging. Its smooth, non-greasy cream base ensures easy absorption, comfortable application, and excellent patient compliance for daily dermatological use.

Sefpil Mandelic Acid Cream, mandelic acid topical cream, AHA exfoliating cream, acne and pigmentation treatment, skin brightening therapy, dermatology formulation, pharmaceutical exporter India, and cosmetic dermatology manufacturer India.

Manufactured in WHO-GMP certified facilities, Sefpil Mandelic Acid Cream meets stringent quality and safety standards to ensure consistent efficacy, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, aesthetic centers, hospitals, retail pharmacies, and international pharmaceutical distributors.

Triglow Cream
Composition: Hydroquinone 2% + Tretinoin 0.05% + Fluocinolone Acetonide 0.01% w/w
International Trade Name: Triple-Action Skin Brightening Cream

Triglow Cream is a high-quality triple-combination dermatological formulation designed for effective management of hyperpigmentation and melasma. It is a reliable generic equivalent of internationally recognized triple-combination creams, manufactured in WHO-GMP certified facilities. Triglow Cream is supplied by trusted pharmaceutical exporters from India, supporting advanced global dermatology and cosmetic treatment programs.

The combination of Hydroquinone, Tretinoin, and Fluocinolone Acetonide delivers targeted skin-lightening and pigment-reducing action. Hydroquinone inhibits melanin synthesis, Tretinoin enhances skin cell turnover to improve pigment reduction, and Fluocinolone Acetonide provides anti-inflammatory support to minimize irritation, enabling safer and more effective treatment of hyperpigmented skin areas.

Triglow Cream is primarily indicated for the treatment of melasma, post-inflammatory hyperpigmentation, and other pigmentary disorders, under medical supervision.

Hydroquinone + Tretinoin + Fluocinolone cream, Triglow cream, triple combination cream, melasma treatment cream, skin brightening therapy, hyperpigmentation cream, dermatology pharmaceutical product, skin care exporter India, topical dermatology cream manufacturer India.

Triglow Cream is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The cream is supplied in tamper-proof, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, cosmetic dermatology centers, hospitals, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Takfa Lipid-Based Ointment – Tacrolimus

Composition:
Tacrolimus Ointment (Lipid-Based Formulation)

Takfa Lipid-Based Ointment is a premium topical immunomodulatory formulation containing Tacrolimus, designed for the management of chronic inflammatory skin disorders such as atopic dermatitis, eczema, and other T-cell mediated dermatoses. The lipid-based vehicle enhances skin penetration, improves moisturization, and increases patient comfort, making it suitable for sensitive and dry skin areas.

Tacrolimus acts by inhibiting calcineurin, thereby reducing T-cell activation and the release of inflammatory cytokines in affected skin. This targeted mechanism controls redness, itching, and inflammation without the risks associated with long-term topical corticosteroid use. The lipid-based formulation further restores the skin barrier, enhances hydration, and reduces irritation, improving overall skin health and treatment outcomes.

Takfa Lipid-Based Ointment is primarily indicated for topical treatment of moderate to severe atopic dermatitis, eczema, and chronic inflammatory skin conditions, particularly in areas prone to dryness or sensitivity, under dermatological supervision. Its smooth, non-greasy lipid-rich ointment base ensures easy application, optimal absorption, and high patient compliance.

Takfa Lipid-Based Ointment, Tacrolimus lipid-based ointment, immunomodulatory dermatology ointment, steroid-sparing therapy, atopic dermatitis treatment, eczema ointment, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Takfa Lipid-Based Ointment adheres to stringent quality and safety standards, ensuring consistent efficacy, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, specialty skin centers, retail pharmacies, and international pharmaceutical distributors.

Tretiva 40 Capsules
Composition: Isotretinoin Capsules 40mg
International Trade Name: Tretiva®

Tretiva 40 is a high-quality oral retinoid formulation containing isotretinoin 40mg, a vitamin A derivative renowned for its potent anti-acne activity. Manufactured in WHO-GMP certified facilities, Tretiva 40 Capsules are supplied by trusted pharmaceutical exporters from India to support advanced dermatology treatment programs worldwide, particularly for severe, nodulocystic, or recalcitrant acne vulgaris.

Isotretinoin acts by reducing sebaceous gland activity, normalizing follicular keratinization, controlling bacterial growth, and exerting anti-inflammatory effects, providing a comprehensive treatment for severe acne. Tretiva 40 is primarily indicated for severe acne unresponsive to conventional topical or systemic therapies, ensuring effective and long-term remission.

Tretiva 40 (Isotretinoin Capsules 40mg), oral retinoid therapy, severe acne management, anti-acne systemic treatment, dermatology medicines exporter India, and oral retinoid manufacturer India.

Tretiva 40 Capsules are manufactured under stringent GMP and dermatological quality standards, ensuring consistent potency, efficacy, and patient safety. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hospitals, acne treatment centers, retail pharmacies, and international pharmaceutical distributors.

ACNON C Gel – Adapalene & Clindamycin
Composition: Adapalene 0.1% + Clindamycin 1%
International Trade Name: Cabtreo®

ACNON C Gel is a high-quality topical formulation combining Adapalene and Clindamycin, a pharmaceutical equivalent of internationally recognized acne therapy products. Manufactured in WHO-GMP certified facilities, ACNON C Gel is supplied by trusted pharmaceutical exporters from India to support advanced dermatology treatment programs, particularly in the management of acne vulgaris.

Adapalene, a third-generation retinoid, normalizes follicular epithelial cell turnover, while Clindamycin, a potent antibiotic, inhibits acne-causing bacterial growth. The synergistic combination targets multiple pathogenic factors in acne, making ACNON C Gel primarily indicated for the treatment of mild to moderate inflammatory and non-inflammatory acne lesions.

ACNON C Gel is manufactured under stringent GMP and dermatology quality standards, ensuring consistent efficacy, safety, and long-term stability. The gel is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, government skin care programs, and international pharmaceutical distributors.

Aziderm 10 Cream
Composition: Azelaic Acid 10% w/w
Dosage Form: Topical Cream

Aziderm 10 Cream is a high-quality dermatological formulation containing Azelaic Acid, widely used for the treatment of acne, hyperpigmentation, and rosacea. Manufactured in WHO-GMP certified facilities, Aziderm 10 ensures consistent quality and effective skin care results.

Azelaic Acid works by reducing the growth of acne-causing bacteria, normalizing keratinization, and lightening hyperpigmented areas. Aziderm 10 Cream is primarily indicated for mild to moderate acne vulgaris, post-inflammatory hyperpigmentation, and melasma under dermatological supervision.

The cream is produced under stringent GMP and pharmaceutical quality standards, ensuring safety, stability, and efficacy. Supplied in secure, consumer-friendly packaging with complete regulatory documentation, Aziderm 10 Cream is suitable for dermatology clinics, hospitals, and pharmacies.

Isotroin – Isotretinoin 20mg Capsules
Composition: Isotretinoin 20mg
International Trade Name: Isotroin®

Isotroin 20mg Capsules are a high-quality oral formulation of isotretinoin, a systemic retinoid widely recognized for its efficacy in severe acne management. Manufactured in WHO-GMP certified facilities, Isotroin Capsules are supplied by trusted pharmaceutical exporters from India to support advanced dermatology treatment programs, particularly for patients with nodulocystic acne unresponsive to conventional therapy.

Isotretinoin works by reducing sebaceous gland activity, normalizing skin cell turnover, and exerting anti-inflammatory effects, thereby addressing the underlying causes of severe acne. Isotroin 20mg Capsules are primarily indicated for the treatment of severe recalcitrant nodular acne and other acne forms as determined by a dermatologist.

Isotroin 20mg Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hospitals, and international pharmaceutical distributors.

Retino A – Tretinoin Cream

Composition:
Tretinoin Cream (0.025%, 0.05%, or 0.1% – depending on the variant)

Retino A Cream is a high-quality topical retinoid formulation containing Tretinoin, widely recognized as a gold-standard therapy for acne vulgaris, photoaging, and hyperpigmentation. This cream works by promoting epidermal cell turnover, preventing comedone formation, and supporting skin renewal for smoother, clearer skin.

Tretinoin normalizes follicular epithelial desquamation, reduces microcomedones, and controls inflammation, effectively treating inflammatory and non-inflammatory acne lesions. It also stimulates collagen production, improving fine lines, uneven texture, and post-acne pigmentation, making Retino A suitable for both therapeutic and cosmetic dermatological use.

Retino A Cream is primarily indicated for the topical treatment of mild to severe acne vulgaris, photo-damaged skin, fine lines, and hyperpigmentation under dermatological supervision. Its smooth, non-greasy cream base ensures easy absorption, high patient compliance, and suitability for daily application.

Retino A Tretinoin Cream, tretinoin topical cream, anti-acne retinoid, acne vulgaris treatment, anti-aging cream, post-acne scar management, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Retino A Cream adheres to stringent quality and safety standards, ensuring consistent potency, stability, and therapeutic efficacy. The product is supplied in secure, hygienic, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Tretiva 20mg Capsules – Isotretinoin

Composition:
Isotretinoin Capsules 20mg

Tretiva 20mg Capsules are a high-quality oral retinoid formulation containing Isotretinoin 20mg, widely prescribed for the treatment of severe and treatment-resistant acne vulgaris. This systemic therapy is indicated for patients who do not respond adequately to conventional treatments such as topical agents and systemic antibiotics.

Isotretinoin acts by significantly reducing sebaceous gland size and sebum production, normalizing follicular keratinization, inhibiting the growth of acne-causing bacteria, and exerting anti-inflammatory effects. These combined actions lead to a marked reduction in nodulocystic acne, severe papulopustular acne, and acne prone to scarring, often resulting in long-term remission when used under strict medical supervision.

Tretiva 20mg Capsules are primarily indicated for severe acne vulgaris, including nodular and cystic forms, especially in cases associated with scarring or psychological distress. The soft gelatin capsule formulation ensures accurate dosing, good oral absorption, and consistent therapeutic outcomes.

Tretiva 20mg, Isotretinoin capsules, oral retinoid therapy, severe acne treatment, nodulocystic acne management, dermatology prescription medicine, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Tretiva Capsules comply with stringent pharmaceutical quality and safety standards, ensuring consistent potency, stability, and clinical efficacy. The product is supplied in secure, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, specialty pharmacies, and international pharmaceutical distributors.

Tretiva 10 mg Capsules
Composition: Isotretinoin Capsules IP 10 mg
International Trade Name: Accutane® / Roaccutane®

Tretiva 10 mg is a high-quality oral isotretinoin formulation, designed for the effective management of severe acne vulgaris that is resistant to conventional treatments. Manufactured in WHO-GMP certified facilities, Tretiva Capsules are supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs.

Isotretinoin is a vitamin A derivative (retinoid) that targets multiple factors in acne pathogenesis. It reduces sebaceous gland activity, decreases sebum production, normalizes follicular keratinization, and exhibits anti-inflammatory effects, leading to the healing of existing lesions, prevention of new breakouts, and long-term remission in severe nodulocystic acne.

Tretiva 10 mg Capsules are primarily indicated for the treatment of severe nodular, cystic, or recalcitrant acne, particularly in patients unresponsive to systemic antibiotics or topical therapies. Use of isotretinoin requires medical supervision due to potential systemic side effects and teratogenicity.

Tretiva 10 mg Capsules, isotretinoin oral capsules, severe acne treatment, retinoid therapy, nodulocystic acne oral medicine, dermatology medicines exporter India, and oral retinoid manufacturer India.

Tretiva 10 mg Capsules are manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and therapeutic reliability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Tacroz Tacrolimus Ointment 0.03%
Composition: Tacrolimus Ointment IP 0.03% w/w
International Trade Name: Protopic® 0.03%

Tacroz is a high-quality Tacrolimus Ointment 0.03%, a pharmaceutical equivalent of the internationally recognized topical immunomodulator marketed under the brand name Protopic®. Manufactured in WHO-GMP certified facilities, Tacroz Ointment is supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs, particularly in atopic dermatitis (eczema) and other inflammatory skin disorders.

Tacrolimus is a topical calcineurin inhibitor that works by suppressing T-cell activation and inhibiting the release of pro-inflammatory cytokines in the skin. Unlike topical corticosteroids, Tacroz Tacrolimus Ointment 0.03% effectively reduces inflammation, redness, and itching without causing skin atrophy, making it especially suitable for sensitive skin areas such as the face, neck, and skin folds. Tacroz 0.03% is primarily indicated for the treatment of moderate to severe atopic dermatitis, particularly in pediatric and adult patients who are unresponsive or intolerant to conventional therapies.

Tacroz Tacrolimus Ointment 0.03%, Protopic equivalent, tacrolimus topical ointment, eczema treatment ointment, calcineurin inhibitor dermatology therapy, steroid-free eczema management, dermatology medicines exporter India, and topical immunosuppressant manufacturer India.

Tacroz Tacrolimus Ointment 0.03% is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and skin tolerability. The ointment is supplied in secure, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, government healthcare programs, retail pharmacies, and international pharmaceutical distributors.

Isotroin 20 mg Capsules
Composition: Isotretinoin 20 mg
International Trade Name: Accutane® / Roaccutane®
Dosage Form: Oral Capsule

Isotroin 20 mg Capsules are a high-quality oral formulation containing Isotretinoin, a vitamin A derivative used for the treatment of severe recalcitrant nodular acne that is unresponsive to conventional therapies. Manufactured in WHO-GMP certified facilities, these capsules ensure consistent quality, safety, and therapeutic efficacy.

Isotretinoin works by reducing sebaceous gland activity, normalizing follicular keratinization, and exerting anti-inflammatory effects, addressing the root causes of severe acne. Isotroin 20 mg Capsules are primarily indicated for adult and adolescent patients with severe nodular or cystic acne under strict dermatological supervision due to potential side effects.

The capsules are produced under stringent GMP and pharmaceutical quality standards, ensuring stability, efficacy, and patient safety. Supplied in secure, export-grade packaging with complete regulatory documentation, Isotroin 20 mg Capsules are suitable for hospitals, dermatology clinics, and pharmacies.

Accufine 40 mg Capsules
Composition: Isotretinoin Capsules IP 40 mg
International Trade Name: Accutane® / Roaccutane®

Accufine 40 mg is a high-quality oral isotretinoin formulation, designed for the treatment of severe, recalcitrant acne that has not responded to conventional therapies, including systemic antibiotics and topical agents. Manufactured in WHO-GMP certified facilities, Accufine Capsules are supplied by trusted pharmaceutical exporters from India to support advanced global dermatology treatment programs.

Isotretinoin is a vitamin A derivative (retinoid) that acts on multiple acne pathways. It reduces sebaceous gland size and sebum production, normalizes keratinization of hair follicles, and provides anti-inflammatory effects, promoting healing of existing lesions, preventing new acne formation, and achieving long-term remission in severe nodulocystic acne.

Accufine 40 mg Capsules are primarily indicated for severe nodular, cystic, or treatment-resistant acne, especially in patients who have failed conventional therapy. Due to its potent systemic effects and teratogenic potential, isotretinoin treatment requires strict medical supervision, regular monitoring, and adherence to recommended dosing protocols.

Accufine 40 mg Capsules, isotretinoin high-dose capsules, severe acne oral therapy, retinoid treatment for nodulocystic acne, dermatology medicines exporter India, and oral retinoid manufacturer India.

Accufine 40 mg Capsules are manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and patient tolerability. The capsules are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Accufine 20 mg Softgel Capsules
Composition: Isotretinoin 20 mg
International Trade Name: Accufine (Isotretinoin Softgel Capsules)

Accufine 20 mg Softgel Capsules is a high-quality oral retinoid formulation designed for the effective management of severe acne vulgaris. It is a reliable generic equivalent of internationally recognized isotretinoin capsules, manufactured in WHO-GMP certified facilities. Accufine Softgel Capsules are supplied by trusted pharmaceutical exporters from India, supporting advanced global dermatology treatment programs.

Isotretinoin is a vitamin A derivative (retinoid) that works by reducing sebaceous gland activity, decreasing sebum production, normalizing skin cell turnover, and exhibiting anti-inflammatory effects. Oral administration of Accufine provides systemic therapeutic action, targeting severe, treatment-resistant acne that has not responded adequately to conventional therapies.

Accufine 20 mg Softgel Capsules are primarily indicated for the treatment of severe nodular or cystic acne, recalcitrant acne vulgaris, and acne with a risk of scarring, under strict medical supervision due to its potent pharmacological profile.

Isotretinoin 20 mg capsules, Accufine softgel, oral retinoid for acne, severe acne treatment, dermatology pharmaceutical product, acne therapy exporter India, isotretinoin manufacturer India.

Accufine 20 mg Softgel Capsules are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for dermatology clinics, hospitals, pharmacies, government healthcare programs, and international pharmaceutical distributors.

Tretinoin 0.05% – A-Ret Gel 0.05

Composition:
Tretinoin Gel 0.05%

A-Ret Gel 0.05 is a high-quality topical retinoid formulation containing 0.05% Tretinoin, designed for the effective management of acne vulgaris and photoaged skin. This gel formulation promotes epidermal cell turnover, helps prevent comedone formation, and supports overall skin renewal, making it a cornerstone therapy in dermatology.

Tretinoin works by normalizing follicular epithelial desquamation, reducing microcomedones, and preventing inflammatory acne lesions. Additionally, it stimulates collagen production and improves skin texture, helping reduce fine lines, post-acne marks, hyperpigmentation, and uneven skin tone.

A-Ret Gel 0.05% is primarily indicated for topical treatment of mild to moderate acne vulgaris and early signs of photoaging, under dermatological supervision. The lightweight, non-greasy gel base ensures quick absorption, enhanced penetration, and high patient compliance, making it suitable for daily use.

Tretinoin 0.05% Gel, A-Ret Gel 0.05, topical retinoid therapy, acne treatment gel, anti-aging retinoid, post-acne scar management, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, A-Ret Gel 0.05 meets stringent quality and safety standards, ensuring consistent potency, stability, and therapeutic efficacy. The product is supplied in secure, hygienic, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

A-Ret Gel 0.1 – Tretinoin Gel

Composition:
Tretinoin Gel 0.1%

A-Ret Gel 0.1 is a high-potency topical retinoid formulation containing 0.1% Tretinoin, widely used for the management of moderate to severe acne vulgaris and photoaged skin. This gel promotes epidermal cell turnover, helps prevent comedone formation, and supports overall skin renewal, making it a cornerstone in dermatological therapy.

Tretinoin works by normalizing follicular epithelial desquamation, reducing microcomedones, and controlling inflammation. It also stimulates collagen production, improving fine lines, uneven skin texture, post-acne pigmentation, and hyperpigmentation, making it suitable for both therapeutic and cosmetic dermatological use.

A-Ret Gel 0.1 is primarily indicated for the topical treatment of moderate to severe acne vulgaris and photoaging under dermatological supervision. The lightweight, non-greasy gel base ensures quick absorption, enhanced penetration, and high patient compliance for daily use.

A-Ret Gel 0.1, Tretinoin 0.1% Gel, topical retinoid therapy, acne treatment gel, anti-aging retinoid, post-acne scar management, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, A-Ret Gel 0.1 meets stringent quality and safety standards, ensuring consistent potency, stability, and therapeutic efficacy. The product is supplied in secure, hygienic, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

V-Meet Tretinoin 0.1% Gel
Composition: Tretinoin 0.1% w/w Gel
International Trade Name: V-Meet®
Reference Brands: Altreno®, Atralin®, Avita®, Retin-A®

V-Meet Tretinoin 0.1% Gel is a high-quality topical retinoid formulation containing tretinoin, a vitamin A derivative extensively used in dermatology for acne treatment and skin renewal therapy. Manufactured in WHO-GMP certified facilities, V-Meet Gel is supplied by trusted pharmaceutical exporters from India to support global dermatology and aesthetic treatment programs.

Tretinoin works by accelerating epidermal cell turnover, preventing comedone formation, reducing inflammation, and promoting collagen synthesis. These actions make V-Meet Tretinoin 0.1% Gel highly effective in the management of moderate to severe acne vulgaris, while also improving skin texture, fine lines, and post-inflammatory hyperpigmentation (PIH). It is widely prescribed for both therapeutic and cosmetic dermatology applications.

V-Meet Tretinoin 0.1% Gel, tretinoin topical gel, Retin-A equivalent, Altreno alternative, anti-acne retinoid therapy, skin rejuvenation treatment, dermatology medicines exporter India, and topical dermatology product manufacturer India.

V-Meet Tretinoin 0.1% Gel is manufactured under stringent GMP and dermatological quality standards, ensuring consistent potency, safety, and skin tolerability. The gel is supplied in secure, patient-friendly, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Aklief Cream – Trifarotene Cream

Composition:
Trifarotene Cream

Aklief Cream is a high-quality topical retinoid formulation containing Trifarotene, a fourth-generation retinoid specifically developed for the treatment of acne vulgaris, including both facial and truncal acne. This advanced cream provides targeted action on retinoic acid receptors (RAR-γ), offering effective normalization of follicular epithelial turnover, anti-inflammatory benefits, and reduction of acne lesions with improved skin tolerability.

Trifarotene works by regulating keratinocyte differentiation, preventing comedone formation, and reducing inflammation, making it highly effective against papules, pustules, and comedonal acne. Its selective receptor activity ensures minimal irritation while maintaining high therapeutic efficacy. The cream also helps improve skin texture and post-acne discoloration, supporting overall skin rejuvenation.

Aklief Cream is primarily indicated for the topical treatment of moderate acne vulgaris on the face, chest, and back under dermatological supervision. Its lightweight, non-greasy cream base allows easy application, rapid absorption, and high patient compliance.

Aklief Cream, Trifarotene topical cream, retinoid acne therapy, facial and truncal acne treatment, comedolytic and anti-inflammatory cream, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Aklief Cream adheres to strict quality and safety standards, ensuring consistent potency, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Tretiheal – Tretinoin 0.025% Cream

Composition:
Tretinoin 0.025% Cream

Tretiheal Cream is a high-quality topical retinoid formulation containing 0.025% Tretinoin, designed for the treatment of acne vulgaris, fine lines, and early photoaging. This gentle yet effective cream promotes epidermal cell turnover, unclogs pores, and reduces comedone formation, helping improve both active acne lesions and post-acne marks.

Tretinoin works by regulating keratinization, reducing inflammation, and stimulating collagen production, which enhances skin texture, minimizes fine lines, and promotes an even skin tone. The 0.025% concentration provides a balanced efficacy with reduced irritation, making it suitable for individuals with sensitive or dry skin.

Tretiheal Cream is primarily indicated for the topical treatment of mild to moderate acne vulgaris, comedonal and inflammatory lesions, post-acne hyperpigmentation, and early signs of photoaging under dermatological supervision. Its smooth, non-greasy cream base ensures easy application, optimal absorption, and high patient compliance.

Tretiheal Tretinoin 0.025% Cream, topical retinoid cream, anti-acne therapy, skin rejuvenation cream, fine line reduction, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Tretiheal Cream adheres to strict quality and safety standards, ensuring consistent efficacy, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

A-Ret Gel 0.025 – Tretinoin Gel

Composition:
Tretinoin Gel 0.025%

A-Ret Gel 0.025 is a topical retinoid formulation containing 0.025% Tretinoin, designed for the treatment of mild to moderate acne vulgaris and early signs of photoaging. This gel promotes epidermal cell turnover, helps prevent comedone formation, and supports skin renewal, offering an effective solution for clearer, healthier-looking skin.

Tretinoin works by normalizing follicular epithelial desquamation, reducing microcomedones, controlling inflammation, and stimulating collagen production. It also helps improve post-acne pigmentation, fine lines, and uneven skin texture, making it suitable for both therapeutic acne management and early anti-aging care.

A-Ret Gel 0.025 is primarily indicated for the topical treatment of mild to moderate acne vulgaris and photo-damaged skin under dermatological supervision. Its lightweight, non-greasy gel base ensures fast absorption, good penetration, and high patient compliance for daily use.

A-Ret Gel 0.025, Tretinoin 0.025% Gel, topical retinoid therapy, acne treatment gel, anti-aging retinoid, post-acne scar management, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, A-Ret Gel 0.025 adheres to strict quality and safety standards, ensuring consistent potency, stability, and therapeutic efficacy. The product is supplied in secure, hygienic, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Tretin 0.025% Cream
Composition: Tretinoin 0.025% w/w Cream
International Trade Name: Tretin®

Tretin 0.025% Cream is a high-quality topical retinoid formulation containing tretinoin, a vitamin A derivative widely recognized for its anti-acne and skin renewal properties. Manufactured in WHO-GMP certified facilities, Tretin Cream is supplied by trusted pharmaceutical exporters from India to support global dermatology and aesthetic treatment programs.

Tretinoin works by promoting skin cell turnover, preventing comedone formation, and reducing inflammation, making it highly effective in the management of mild to moderate acne vulgaris. Additionally, it helps improve skin texture, reduce fine wrinkles, and lighten post-inflammatory hyperpigmentation (PIH). Tretin 0.025% Cream is primarily indicated for acne vulgaris, early photoaging, and skin rejuvenation therapy in adult patients.

Tretin 0.025% Tretinoin Cream, topical retinoid therapy, anti-acne cream, skin renewal and rejuvenation cream, dermatology medicines exporter India, and topical dermatology product manufacturer India.

Tretin 0.025% Cream is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and skin tolerability. The cream is supplied in secure, patient-friendly, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.

Trunex MS – Tretinoin Microsphere Gel

Composition:
Tretinoin Microsphere Gel 0.04% / 0.1% (depending on variant)

Trunex MS Gel is a advanced topical retinoid formulation containing Tretinoin in microsphere technology, designed for the effective treatment of acne vulgaris and photoaged skin. The microsphere delivery system allows for controlled release of Tretinoin, reducing skin irritation while maintaining therapeutic efficacy.

Tretinoin works by normalizing follicular epithelial desquamation, preventing comedone formation, reducing inflammatory acne lesions, and stimulating collagen production. The microsphere technology ensures gradual absorption, minimizing irritation, redness, and peeling commonly associated with conventional retinoid therapy, making Trunex MS suitable for sensitive skin and long-term use.

Trunex MS Gel is primarily indicated for the topical treatment of mild to moderate acne vulgaris, inflammatory and non-inflammatory lesions, post-acne marks, and early signs of photoaging, under dermatological supervision. Its lightweight, non-greasy gel base ensures fast absorption, high patient compliance, and easy application.

Trunex MS Tretinoin Microsphere Gel, tretinoin microsphere gel, controlled-release retinoid, acne treatment gel, anti-aging retinoid, post-acne scar management, dermatology formulation, pharmaceutical exporter India, and dermatology product manufacturer India.

Manufactured in WHO-GMP certified facilities, Trunex MS Gel meets stringent quality and safety standards, ensuring consistent potency, stability, and skin tolerance. The product is supplied in hygienic, tamper-evident, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, retail pharmacies, and international pharmaceutical distributors.

Tretoin 0.1% Microsphere Gel
Composition: Tretinoin 0.1% w/w Microsphere Gel
International Trade Name: Tretoin®

Tretoin 0.1% Microsphere Gel is a high-quality advanced topical retinoid formulation containing tretinoin microspheres, designed for controlled-release and enhanced skin tolerability. Manufactured in WHO-GMP certified facilities, Tretoin Gel is supplied by trusted pharmaceutical exporters from India to support global dermatology treatment programs, particularly for moderate to severe acne vulgaris and anti-aging skin therapy.

Tretinoin, a vitamin A derivative, works by accelerating skin cell turnover, normalizing follicular keratinization, reducing comedone formation, and controlling inflammation. The microsphere delivery system ensures gradual release of tretinoin, minimizing local irritation while maintaining maximum therapeutic efficacy. Tretoin 0.1% Gel is primarily indicated for moderate to severe acne vulgaris, including papules, pustules, and comedones, and can also be used in photoaged skin to reduce fine wrinkles and improve skin texture.

Tretoin 0.1% Tretinoin Microsphere Gel, topical retinoid gel, controlled-release acne therapy, anti-acne and skin rejuvenation treatment, dermatology medicines exporter India, and topical dermatology product manufacturer India.

Tretoin 0.1% Gel is manufactured under stringent GMP and dermatological quality standards, ensuring consistent efficacy, safety, and skin tolerability. The gel is supplied in secure, patient-friendly, export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, aesthetic centers, retail pharmacies, and international pharmaceutical distributors.